Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis

Virginia L. Stauffer, Michael Case, Bruce J. Kinon, Robert Conley, Haya Ascher-Svanum, Sara Kollack-Walker, John Kane, Joseph Patrick McEvoy, Jeffrey Lieberman

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Early response to antipsychotic medication has been shown to accurately predict later response to continued use of the same treatment in patients with chronic schizophrenia. This study examines whether this predictive pattern exists for patients with first-episode psychosis. We used a data-driven threshold for early response of ≥26.2% improvement from baseline on the Positive and Negative Syndrome Scale (PANSS0-6) Total score to determine whether response at Week 2 of treatment may predict response at Week 12 in a randomized, double-blind trial of olanzapine versus haloperidol for treatment of patients with first-episode psychosis (N=225). Later response was defined as a ≥40% and ≥50% improvement in PANSS Total0-6 score and as remission. At Week 2, 43% (97/225) of patients were identified as early responders. At a threshold for later response of ≥50% improvement in PANSS0-6 Total score, early non-response most strongly predicted later non-response, demonstrating high specificity (74%) and high negative predictive value (80%). As had been seen in the treatment of patients with chronic schizophrenia, early non-response was a robust predictor of subsequent non-response in the treatment of patients with first-episode psychosis.

Original languageEnglish (US)
Pages (from-to)42-48
Number of pages7
JournalPsychiatry Research
Volume187
Issue number1-2
DOIs
StatePublished - May 15 2011
Externally publishedYes

Fingerprint

Psychotic Disorders
Antipsychotic Agents
Biomarkers
olanzapine
Schizophrenia
Therapeutics
Haloperidol

Keywords

  • Haloperidol
  • Olanzapine
  • Prediction models
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Stauffer, V. L., Case, M., Kinon, B. J., Conley, R., Ascher-Svanum, H., Kollack-Walker, S., ... Lieberman, J. (2011). Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. Psychiatry Research, 187(1-2), 42-48. https://doi.org/10.1016/j.psychres.2010.11.017

Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. / Stauffer, Virginia L.; Case, Michael; Kinon, Bruce J.; Conley, Robert; Ascher-Svanum, Haya; Kollack-Walker, Sara; Kane, John; McEvoy, Joseph Patrick; Lieberman, Jeffrey.

In: Psychiatry Research, Vol. 187, No. 1-2, 15.05.2011, p. 42-48.

Research output: Contribution to journalArticle

Stauffer, VL, Case, M, Kinon, BJ, Conley, R, Ascher-Svanum, H, Kollack-Walker, S, Kane, J, McEvoy, JP & Lieberman, J 2011, 'Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis', Psychiatry Research, vol. 187, no. 1-2, pp. 42-48. https://doi.org/10.1016/j.psychres.2010.11.017
Stauffer, Virginia L. ; Case, Michael ; Kinon, Bruce J. ; Conley, Robert ; Ascher-Svanum, Haya ; Kollack-Walker, Sara ; Kane, John ; McEvoy, Joseph Patrick ; Lieberman, Jeffrey. / Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. In: Psychiatry Research. 2011 ; Vol. 187, No. 1-2. pp. 42-48.
@article{1d07623af9ae4bef9a75508c3c1c1384,
title = "Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis",
abstract = "Early response to antipsychotic medication has been shown to accurately predict later response to continued use of the same treatment in patients with chronic schizophrenia. This study examines whether this predictive pattern exists for patients with first-episode psychosis. We used a data-driven threshold for early response of ≥26.2{\%} improvement from baseline on the Positive and Negative Syndrome Scale (PANSS0-6) Total score to determine whether response at Week 2 of treatment may predict response at Week 12 in a randomized, double-blind trial of olanzapine versus haloperidol for treatment of patients with first-episode psychosis (N=225). Later response was defined as a ≥40{\%} and ≥50{\%} improvement in PANSS Total0-6 score and as remission. At Week 2, 43{\%} (97/225) of patients were identified as early responders. At a threshold for later response of ≥50{\%} improvement in PANSS0-6 Total score, early non-response most strongly predicted later non-response, demonstrating high specificity (74{\%}) and high negative predictive value (80{\%}). As had been seen in the treatment of patients with chronic schizophrenia, early non-response was a robust predictor of subsequent non-response in the treatment of patients with first-episode psychosis.",
keywords = "Haloperidol, Olanzapine, Prediction models, Schizophrenia",
author = "Stauffer, {Virginia L.} and Michael Case and Kinon, {Bruce J.} and Robert Conley and Haya Ascher-Svanum and Sara Kollack-Walker and John Kane and McEvoy, {Joseph Patrick} and Jeffrey Lieberman",
year = "2011",
month = "5",
day = "15",
doi = "10.1016/j.psychres.2010.11.017",
language = "English (US)",
volume = "187",
pages = "42--48",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis

AU - Stauffer, Virginia L.

AU - Case, Michael

AU - Kinon, Bruce J.

AU - Conley, Robert

AU - Ascher-Svanum, Haya

AU - Kollack-Walker, Sara

AU - Kane, John

AU - McEvoy, Joseph Patrick

AU - Lieberman, Jeffrey

PY - 2011/5/15

Y1 - 2011/5/15

N2 - Early response to antipsychotic medication has been shown to accurately predict later response to continued use of the same treatment in patients with chronic schizophrenia. This study examines whether this predictive pattern exists for patients with first-episode psychosis. We used a data-driven threshold for early response of ≥26.2% improvement from baseline on the Positive and Negative Syndrome Scale (PANSS0-6) Total score to determine whether response at Week 2 of treatment may predict response at Week 12 in a randomized, double-blind trial of olanzapine versus haloperidol for treatment of patients with first-episode psychosis (N=225). Later response was defined as a ≥40% and ≥50% improvement in PANSS Total0-6 score and as remission. At Week 2, 43% (97/225) of patients were identified as early responders. At a threshold for later response of ≥50% improvement in PANSS0-6 Total score, early non-response most strongly predicted later non-response, demonstrating high specificity (74%) and high negative predictive value (80%). As had been seen in the treatment of patients with chronic schizophrenia, early non-response was a robust predictor of subsequent non-response in the treatment of patients with first-episode psychosis.

AB - Early response to antipsychotic medication has been shown to accurately predict later response to continued use of the same treatment in patients with chronic schizophrenia. This study examines whether this predictive pattern exists for patients with first-episode psychosis. We used a data-driven threshold for early response of ≥26.2% improvement from baseline on the Positive and Negative Syndrome Scale (PANSS0-6) Total score to determine whether response at Week 2 of treatment may predict response at Week 12 in a randomized, double-blind trial of olanzapine versus haloperidol for treatment of patients with first-episode psychosis (N=225). Later response was defined as a ≥40% and ≥50% improvement in PANSS Total0-6 score and as remission. At Week 2, 43% (97/225) of patients were identified as early responders. At a threshold for later response of ≥50% improvement in PANSS0-6 Total score, early non-response most strongly predicted later non-response, demonstrating high specificity (74%) and high negative predictive value (80%). As had been seen in the treatment of patients with chronic schizophrenia, early non-response was a robust predictor of subsequent non-response in the treatment of patients with first-episode psychosis.

KW - Haloperidol

KW - Olanzapine

KW - Prediction models

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=79953079202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953079202&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2010.11.017

DO - 10.1016/j.psychres.2010.11.017

M3 - Article

C2 - 21168920

AN - SCOPUS:79953079202

VL - 187

SP - 42

EP - 48

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 1-2

ER -